ReviewCardiovascular drugs and therapy2021
Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective.
Xiaoming Jia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it